Circulating levels and ex vivo production of beta-chemokines, interferon gamma, and interleukin 2 in advanced human immunodeficiency virus type 1 infection: the effect of protease inhibitor therapy.

De Luca, A

Circulating levels and ex vivo production of beta-chemokines, interferon gamma, and interleukin 2 in advanced human immunodeficiency virus type 1 infection: the effect of protease inhibitor therapy. [electronic resource] - AIDS research and human retroviruses Jun 2000 - 835-43 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0889-2229

10.1089/08892220050042774 doi


CD4 Lymphocyte Count
Case-Control Studies
Chemokine CCL3
Chemokine CCL4
Chemokine CCL5--biosynthesis
Chemokines, CC--biosynthesis
HIV Infections--drug therapy
HIV Protease Inhibitors--therapeutic use
HIV-1--isolation & purification
Humans
In Vitro Techniques
Indinavir--therapeutic use
Interferon-gamma--biosynthesis
Interleukin-2--biosynthesis
Leukocytes, Mononuclear--immunology
Macrophage Inflammatory Proteins--biosynthesis
RNA, Viral--blood
Ritonavir--therapeutic use